help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0236
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/12/2839    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farboud, B.
Right arrow Articles by Privalsky, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farboud, B.
Right arrow Articles by Privalsky, M. L.
Molecular Endocrinology 18 (12): 2839-2853
Copyright © 2004 by The Endocrine Society

Retinoic Acid Receptor-{alpha} Is Stabilized in a Repressive State by Its C-Terminal, Isotype-Specific F Domain

Behnom Farboud and Martin L. Privalsky

Section of Microbiology, Division of Biological Sciences, University of California at Davis, Davis, California 95616

Address all correspondence and requests for reprints to: Martin L. Privalsky, Section of Microbiology, Division of Biological Sciences, One Shields Avenue, University of California at Davis, Davis, California 95616. E-mail: mlprivalsky{at}ucdavis.edu.

Retinoic acid receptors (RARs) are hormone-regulated transcription factors that play multiple roles in vertebrate development and differentiation. Three isotypes of RARs, {alpha}, ß, and {gamma}, are encoded by distinct genetic loci and possess distinct transcriptional properties. Typically, RAR{alpha} represses target gene transcription in the absence of hormone, whereas RARß and {gamma} fail to repress under these conditions. This inability of RARß and RAR{gamma} to repress transcription is due to intramolecular interactions between helix 3 and helix 12 of the hormone binding domains of these isotypes that inhibit corepressor binding while favoring coactivator binding. We report here that the converse ability of RAR{alpha} to repress requires the integrity of the receptor F domain, a domain that maps C-terminal to helix 12, varies in sequence among different nuclear receptors, and is of poorly understood function. The F domain appears to help stabilize helix 12 of RAR{alpha} in a more open position that enhances corepressor binding and inhibits coactivator binding in the absence of hormone. Intriguingly, the RAR{alpha} F domain is isotype autonomous in its function. We speculate that the RAR{alpha} F domain may dock elsewhere on the receptor surface, and this intramolecular interaction may maintain RAR{alpha} helix 12 in an open, repression-competent conformation.

NURSA Molecule Pages Link:

Nuclear Receptors:   RARα  |  RARβ  |  RARγ  |  PR
Coregulators:   SRC-1  |  AIB1  |  SMRT
Ligands:   all-trans-Retinoic acid



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
A. Koide, C. Zhao, M. Naganuma, J. Abrams, S. Deighton-Collins, D. F. Skafar, and S. Koide
Identification of Regions within the F Domain of the Human Estrogen Receptor {alpha} that Are Important for Modulating Transactivation and Protein-Protein Interactions
Mol. Endocrinol., April 1, 2007; 21(4): 829 - 842.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. A. Elhaji, I. Stoica, S. Dennis, E. O. Purisima, and M. A. Trifiro
Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity
Hum. Mol. Genet., March 15, 2006; 15(6): 921 - 931.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Wan, B. Farboud, and M. L. Privalsky
Pituitary Resistance to Thyroid Hormone Syndrome Is Associated with T3 Receptor Mutants that Selectively Impair {beta}2 Isoform Function
Mol. Endocrinol., June 1, 2005; 19(6): 1529 - 1542.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society